{
    "startDate": "2019-01-01",
    "endDate": "2019-03-31",
    "year": "2019",
    "quarter": "Q1",
    "symbol": "SNSS",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 24811000
            },
            {
                "label": "Prepaids and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 1599000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 26410000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 9000
            },
            {
                "label": "Operating lease right-of-use asset",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 1226000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 109000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 27754000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 861000
            },
            {
                "label": "Carrying value as of the balance sheet date of obligations incurred through that date and payable, pertaining to costs that are related to clinical trials for which invoices have not yet been received or will not be rendered. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                "concept": "snss:AccruedClinicalExpenseCurrent",
                "unit": "usd",
                "value": 420000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 677000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1440000
            },
            {
                "label": "Notes payable",
                "concept": "NotesPayableCurrent",
                "unit": "usd",
                "value": 6032000
            },
            {
                "label": "Operating lease liability - current",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 545000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 9975000
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 12000
            },
            {
                "label": "Operating lease liability - long term",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 681000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 10668000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Convertible preferred stock",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 25647000
            },
            {
                "label": "Common stock",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 7000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 656761000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -665329000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 17086000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 27754000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -5860000
            },
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 417000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Amortization of debt discount and debt issuance costs",
                "concept": "AmortizationOfFinancingCostsAndDiscounts",
                "unit": "usd",
                "value": 42000
            },
            {
                "label": "Prepaids and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 91000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -532000
            },
            {
                "label": "The net change during the reporting period in the obligations incurred and payable, pertaining to costs that are related to clinical trials for which invoices have not yet been received or will not be rendered.",
                "concept": "snss:IncreaseDecreaseInAccruedClinicalExpense",
                "unit": "usd",
                "value": -80000
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -266000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": 255000
            },
            {
                "label": "Cash flows from operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -6113000
            },
            {
                "label": "Principal payments on notes payable",
                "concept": "RepaymentsOfNotesPayable",
                "unit": "usd",
                "value": 1406000
            },
            {
                "label": "Proceeds from issuance of convertible preferred stock offering, net",
                "concept": "ProceedsFromIssuanceOfConvertiblePreferredStock",
                "unit": "usd",
                "value": 7944000
            },
            {
                "label": "Proceeds from issuance of common stock, net",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 10690000
            },
            {
                "label": "Cash flows from financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 17228000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 11115000
            },
            {
                "label": "Conversion of preferred stock to common stock",
                "concept": "ConversionOfStockAmountConverted1",
                "unit": "usd",
                "value": 3228000
            },
            {
                "label": "Legal expenses accrued as cost of equity financing.",
                "concept": "snss:LegalExpensesAccruedAsCostOfEquityFinancing",
                "unit": "usd",
                "value": -98000
            }
        ],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 3248000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2439000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 5687000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -5687000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 261000
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 88000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -5860000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -5860000
            },
            {
                "label": "Shares used in computing net loss per common share",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 59142000
            },
            {
                "label": "Basic and diluted loss per common share:",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.1
            }
        ]
    }
}